Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Size: px
Start display at page:

Download "Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function"

Transcription

1 Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

2 Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis in the absence of lumen compromise - mostly in reference segments Regardless of the definition, assessing lesion remodeling requires a comparison to the reference segment Positive (outward) remodeling in ACS Negative (constrictive or inward) remodeling in stenosis formation in chronic stable angina

3 Reference Segments Lesions Positive remodeling Intermediate remodeling Negative remodeling Mintz et al, J Am Coll Cardiol 1995;25: Nishioka et al. J Am Coll Cardiol 1996; 27:

4 1) Glagov.. N Engl J Med 1987;316: ) Mintz.. Circulation 1997;95: ) Nishioka.. JACC 1996;27: ) Lim. Circulation. 1997;95: ) Tauth.. AJC 1997;8: ) Kornowski.. AJC 1998; 81: ) Schwarzacher.. Circulation 1998;98:I ) Schoenhagen.. Circulation 2;11: ) Sabate.. AJC 1999;84: ) von Birgelen.. JACC 21;37: ) Kawagoe.. Circulation 1998;98:I ) Mintz.. JACC 1995;25: ) Dangas.. Circulation1999;99: ) Weissman.. AJC 1999;84: ) Hong. Am Heart J 2;14: ) Abizaid.. JACC 1999;33:53A 17) Wexberg.. JACC 2;36: ) Mehran.. Circulation 2;11: ) Taylor. JACC 1999;34:76-7 2) Nakamura. JACC 21;37: ) Pethig.. Am Heart J 1998;135: ) Kobashigawa.. J Heart Lung Transplant 2;19: ) Endo. JACC 21;37:7-5 24) Okura. JACC 21 (in press) 25) Nishioka.. AJC 21;87: ) Gyongyosi. Coron Artery Dis 1999;1: ) Ward. Atherosclerosis 21;154: Rem Intermediate -Rem Plaque burden Plaque burden Reference segment disease (12) Advanced fibrocalcific Early atherosclerosis (1) disease (2,5,9) Soft plaques (9) Chronic stable angina or old MI (2,3,5,14,17,2) Acute coronary syndromes (7,8,1,11,16,2) Hypercholesterolemia (5) High HDL-cholesterol (19) Increased restenosis and CK-MB post-pci (13,17,18,23,24) New stenosis in another location (17) Advanced age (26) Smoking (5,14) Insulin-treated DM (6) Vasospastic angina (15) Transplant atherosclerosis (4,21,22) Proximal disease, eccentric Ostial,, distal disease, lesions surrounded by eccentric lesions surrounded pericardium (9,25) by myocardium (9,25,27)

5 Remodeling in Acute Coronary Syndromes Proximal reference EEM CSA (mm 2 ) Lumen CSA (mm 2 ) ACS 15.2±5, 5, 2 9.1±3.6 Stable 14.2± ±2.8 p ACS Stable P=.1 P&M CSA (mm 2 ) 6.1± ± Lesion EEM CSA (mm 2 ) Lumen CSA (mm 2 ) 16.1± ± ± ± P&M CSA (mm 2 ) Remodeling Index 13.9± ± ±4.8.94± Positive No Negative Remodeling Schoenhagen et al. Circulation 2;11:598-63

6 Diabetes Modulates Remodeling in ACS and Stable Angina (n=927) Frequency of Positive Remodeling Acute Coronary Syndrome Stable Angina DM 59/183 (32.%) 17/88 (19.6%) No DM 225/469 (48.%) 42/187 (22.3%) Abizaid,, unpublished observations

7 In Some Patients with Chronic Stable Angina Negative Remodeling Appears to Occur Early During Stenosis Formation 14 intermediate stenoses 274 RCA stenoses, stratified (QCA DS<6%) according to reference disease 6 5 Negative remodeling Intermediate remodeling 5 45 Positive remodeling Negative Remodeling Intermediate Remodeling Positive Remodeling <2% (n=91) 2-4% (n=91) 4-6% (n=92) Reference plaque burden Hirose M, AJC in press Hong M-K, M JACC in press

8 244 Patients with Stable Angina and Single Vessel Intervention 5 Positive Pre-PCI Remodeling (n=7) Intermediate Pre-PCI Remodeling (n=11) Negative Pre-PCI Remodeling (n=64) 4 3 p=.24 p=.36 p= MACE (%) Target Lesion Restenosis (%) New Stenosis Formation (%) Wexberg et al. J Am Coll Cardiol 2;36:186-9

9 Important IVUS Observations: Lesion Morphology Acute Acute coronary syndromes Hypoechoic plaque Eccentric lesions Ruptured plaques Thrombus-containing plaques in ACS Fibrocalcific plaque in chronic stable angina in association with negative remodeling Positive Positive remodeling and unstable lesion morphologies - i.e., ruptured and thrombus-containing plaques - tend to occur together in ACS

10 Plaque Composition in Acute Coronary Syndromes p=.2 ACS Stable p=ns p=ns p=ns Echolucent Echodense Mixed Calcific Schoenhagen et al. Circulation 2;11:598-63

11 Comparison of Patients with ACS, no MI within 3 weeks, Single de novo Culprit Lesion Troponin (+) vs Troponin (-) p=.4 Plaque rupture (%) Troponin + (n=4) Troponin - (n=45) p=.3 p=.48 p=.17 Dissection (%) Thrombus (%) Any unstable morphology (%) Fuchs et al. Am J Cardiol 22;89:1111-3

12 Three Vessel IVUS Imaging in 24 Pts with ACS and Positive Tn 5 ruptured plaques 9 culprit lesion 41 nonculprit lesion 19 pts had at least 1 nonculprit plaque rupture 17 pts had 1 plaque rupture in a second artery 3 pts had plaque ruptures in all 3 arteries Rioufol et al Circulation 22;16: % # of Ruptured Plaques

13 3 plaque ruptures in 257 arteries of 254 pts Asymptomatic Stable angina Peri MI USA 46% 11% 11% 32% The frequency of stable angina or no symptoms in patients with plaque rupture suggests that asymptomatic rupture and healing are common and may be one of the mechanisms of progression of CAD Thrombus in 46% more frequent in pts with USA or peri-mi, p=.2 more frequent in arteries with multiple rupture sites, p=.4 Ca ++ in 55%, arc=36±47 located at the base of the rupture in 86% Tear in fibrous cap identified in 59%, at shoulder of plaque in 68% in center of plaque in 32% Multiple rupture sites in 14% of ACS patients Maehara et al J Am Coll Cardiol 22;4:94-1

14 22 patients with single de novo lesions studied using angioscopy and IVUS showed a relationship between thrombus and remodeling Complex lesions (irregular surface ±thrombus) Simple lesions (smooth surface w/o thrombus) Positive Remodeling (Lesion EEM>1.5 Reference) 8 1 Negative Remodeling (Lesion EEM<.95 Reference) 2 5 Smits et al. Cardiovasc Res 1999;41: p=.35

15 Culprit Lesion Morphology vs Remodeling in 6 Patients with Unstable Angina 1 Frequency of Plaque Rupture 1 Frequency of Thrombus Positive Intermediate Remodeling Negative Positive Intermediate Negative Remodeling Gyongyosi et al. Heart 1999;82:68-74

16 Remodeling vs plaque composition IVUS & histology in 29 patients (17 stable angina, 12 ACS) treated with DCA Remodeling index 1.2 IVUS & OCT in 82 lesions in 5 patients Remodeling index Inflammatory Lipid score cells Lipid rich* Mixed Fibrous *Remodeling also correlated with quadrants of lipid (p=.1) Uemura et al. ACC 23 Mac Neill et al. ACC 23

17 Calcium Does Not Increase the Biomechanical Instability of Atherosclerotic Plaques! Stable (n=1) Ruptured (n=1) p Ca ++ CSA (%) Lipid CSA (%) Calcium Lipid Maximal stress (kpa( kpa) x=stable x=ruptured kpa 16 x x x x x xx x x x x x x x p=ns x x x 3 % area of calcium Huang. Circulation 21;13:151-6 kpa 16 x x x xx x x x x x x p=.24 x x x x x x x 6 % area of lipid When fibrous plaque was replaced with calcium, stress changed insignificantly (p=.85). In contrast, stress decreased by 26% (p=.2) when lipid was replaced with fibrous plaque.

18 Multiple studies have shown that EBCT calcium score predicts acute coronary events at 1 year follow-up # with no events (n=1155) # with events (n=18) MACE (n=1172) Specificity Sensitivity Square Root of Calcium Score Death/MI (n=1172) Specificty Specificity Square Root of Calcium Score Arad et al. Circulation 1996;93: Sensitivity Square Root of Calcium Score 6 Arad et al. J Am Coll Cardiol 2;36:

19 Important IVUS Observations: Calcium If calcium is uncommon in ACS lesions and if calcium does not affect plaque vulnerability and instability, why does the EBCT calcium score predict acute events?

20 Volumetric IVUS analysis of 19 RCA's with 1 or 2 focal de novo stenoses EEM vol (mm 3 ) Lumen vol (mm 3 ) P&M vol (mm 3 ) Length (mm) Lesion 119 ± ±3 9 ± ±7.6 Non- Stenotic Segment 459 ± ± ± ±13.5 p <.1 <.1 <.1 <.1 72±12% of the plaque volume (range 46-86%) is in nonstenotic segments. Plaque volume l t ith l i Volumetric index of total calcium r=.57, p= Total plaque volume (mm 3 ) Tinana et al. Am J Cardiol 22;89:757-6

21 Proximal 3mm 12mm EEM CSA = 21.mm 2 Lumen CSA = 9.5mm 2 P+M CSA = 11.5mm 2 EEM CSA = 23.5mm 2 Lumen CSA = 5.5mm 2 P+M CSA = 18.mm 2 EEM CSA = 13.7mm 2 Lumen CSA = 9.3mm 2 P+M CSA = 4.4mm 2

22 1mm 4mm

23 2mm 6mm

24 Important IVUS Observations: Lumen Compromise What What separates lesions with asymptomatic plaque rupture from plaque ruptures that cause acute symptoms?

25 Clinical Follow up in 357 intermediate lesions in 3 pts deferred intervention after IVUS imaging IVUS MLD (mm) 4 3 Death/MI/TLR TLR DM no-dm r= QCA MLD (mm) IVUS MLA (mm 2 ) Independent predictors of death/mi/tlr was IVUS MLA (p=.41) Independent predictors of TLR were DM (p=.493) and IVUS MLA (p=.42) Although the number of patients with death and MI was small (n=6), the only independent predictor was IVUS MLD (p=.498). 1 5 IVUS MLA (mm 2 )

26 42 Consecutive Pts with Angiography Both Before and After MI Risk of MI 29 patients had a newly 14 occluded artery 12 In 19 pts, the artery 1 previously had a <5% DS 8 In only 1 pts the 6 occlusion was at the 4 site of the most severe 2 stenosis Little et al. Circulation 1988;78: Pts in CASS after Baseline Angiography Risk of Anterior MI within 3 years (%) Baseline QCA DS (%) Ellis et al. J Am Coll Cardiol 1988;11: "Because the aggregate risk of rupture associated with many non-significant lesions (each with an admitedly lower individual risk potential) exceeds that of the fewer significant lesions, an MI will more likely originate from a nonsignificant lesion." Kern and Meier. Circulation 21;13:3142-9

27 Comparison of Culprit and Non-Culprit Rupture Sites in ACS Patients with Rupture Sites in Non-ACS Patients ACS Culprit Plaque Ruptures (N=35) ACS Non-Culprit Plaque Ruptures (N=2) Non-ACS Plaque Ruptures (N=27) p= p= p= Rupture Site Remodeling Index Minimum Lumen Area (mm 2 ) Thrombus (%) Independent predictors of ACS were MLA and thrombus (both p=.1) Fuji et al. Unpublished Observations

28 Limitations of IVUS Measurement of fibrous cap Histologic studies suggest that the fibrous cap in vulnerable plaques measures <65 microns IVUS resolution is >1 microns Assessment of plaque composition

29 IVUS Can Measure Fibrous Cap Thickness In Vitro, but NOT In Vivo Hiro et al. Circulation 21;13:

30 Virtual Histology db MHz Fibrous, Fibrofatty, Lipidic-necrotic, Calcium

31 Predictive Accuracies of Training and Test Datasets Fibrous (n=11) Fibro-Lipidic (n=56) Calcified (n=5) Lipidic-Necrotic (n=7) Training Test Training Test Training Test Training Test FFT^ Welch AR

32 Ex-Vivo Validation Virtual Histology Fibrous, Fibro-lipidic, Lipidic-necrotic, Calcium

33 Ex-Vivo Validation Virtual Histology Fibrous, Fibro-lipidic, Lipidic-necrotic, Calcium

34 What about IVUS compared with other invasive diagnostic modalities? IVUS Structure + Plaque Composition Fibrous Cap Function Safe Validated in vivo Practical Available + IVUS+Virtual Histology + + OCT Thermography + Palpography + +

35 Conclusions Almost everything that we know about IVUS and vulnerable plaque has come from extrapolating studies of IVUS in ACS - NOT from prospective correlative studies Culprit lesions in ACS are, in general, characterized by Positive Positive remodeling Hypoechoic,, eccentric, ruptured plaques with evidence of thrombus With With a complex interaction between remodeling and plaque composition and instability in ACS. Positive remodeling Prevents lumen compromise "Paradoxically" may contribute to ACS and to MACE after PCI May May be less common in diabetics with ACS Negative remodeling Contributes to lumen compromise Probably can occur both early and late Calcium is a marker of plaque mass, not a determinant of instability

36 But... The relationship between ACS/MI, positive remodeling, "vulnerable" le" plaques, and ruptured plaques may not be so simple. Frequency of an MI is related to the severity of the underlying stenosis Not Not all pts with ACS/MI have positive remodeling Not Not all pts with ACS/MI have plaque rupture Not Not all ruptured plaques cause ACS/MI. In some pts plaque rupture re is asymptomatic and may be followed by healing, negative remodeling, calcification, and disease progression. In other patients the development of a thrombus (superimposed on plaque rupture) decreased lumen dimensions and results in ACS/MI While While the concept of using multiple complementary imaging techniques may seem attractive, any clinical approach must be practical and safe.

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything

More information

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of

More information

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Research Foundation and Columbia University Medical Center, New York. Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Can IVUS Define Plaque Features that Impact Patient Care?

Can IVUS Define Plaque Features that Impact Patient Care? Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly

More information

Coronary Artery Thermography

Coronary Artery Thermography Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In

More information

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Assessment of Vulnerable Plaque by IVUS and VH-IVUS Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research

More information

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,

More information

Between Coronary Angiography and Fractional Flow Reserve

Between Coronary Angiography and Fractional Flow Reserve Visual-Functional Mismatch Between Coronary Angiography and Fractional Flow Reserve Seung-Jung Park, MD., PhD. University of Ulsan, College of Medicine Asan Medical Center, Seoul, Korea Visual - Functional

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea Anatomical vs Functional Significance? Coronary Angiogram Treadmill Test Tc-99m-MIBI SPECT MDCT Coronary Angiogram

More information

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular

More information

The Site of Plaque Rupture in Native Coronary Arteries

The Site of Plaque Rupture in Native Coronary Arteries Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.067

More information

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart

More information

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT

More information

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular

More information

Plaque Shift vs. Carina Shift Prevalence and Implication

Plaque Shift vs. Carina Shift Prevalence and Implication TCTAP 2013 Fellowship Course Left Main and Bifurcation PCI: Bifurcation PCI Plaque Shift vs. Carina Shift Prevalence and Implication Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan

More information

Assessment of plaque morphology by OCT in patients with ACS

Assessment of plaque morphology by OCT in patients with ACS Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events

More information

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD.

IVUS-Guided d Provisional i Stenting: Plaque or Carina Shift. Soo-Jin Kang, MD., PhD. Left Main and Bifurcation Summit IVUS-Guided d Provisional i Stenting: ti Plaque or Carina Shift Soo-Jin Kang, MD., PhD. Department of Cardiology, University of Ulsan College of Medicine Asan Medical Center,

More information

OCT Findings: Lesson from Stable vs Unstable Plaques

OCT Findings: Lesson from Stable vs Unstable Plaques ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment

More information

Chapter 43 Noninvasive Coronary Plaque Imaging

Chapter 43 Noninvasive Coronary Plaque Imaging hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate

More information

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation

Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes. Gary S. Mintz, MD Cardiovascular Research Foundation Integrating IVUS, FFR, and Noninvasive Imaging to Optimize Outcomes Gary S. Mintz, MD Cardiovascular Research Foundation COURAGE Nuclear Substudy (n=314) Death/MI according the residual ischemia (SPECT)

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /

More information

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department

More information

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy

More information

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57: Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging Imaging the Vulnerable Plaque David A. Dowe, MD Atlantic Medical Imaging Why is this so important? The Acute Situation Coronary disease-important Diagnosis of cardiovascular disease cost $148 billion in

More information

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation

IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation IVUS Assessment of the Mechanism of In-stent Restenosis? Gary S. Mintz, MD Cardiovascular Research Foundation SURE Trial: Restenosis in non-stented lesions Average of the two image slices with the smallest

More information

Left main coronary artery (LMCA): The proximal segment

Left main coronary artery (LMCA): The proximal segment Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary

More information

Angiographic Geometric Predictors of Myocardial Infarction Are Not Associated with Ultrasonographic Markers of Plaque Vulnerability CONCLUSION

Angiographic Geometric Predictors of Myocardial Infarction Are Not Associated with Ultrasonographic Markers of Plaque Vulnerability CONCLUSION Article Original Article Angiographic Geometric Predictors of Myocardial Infarction Are Not Associated with Ultrasonographic Markers of Plaque Vulnerability Celso Kiyochi Takimura, Pedro Alves Lemos, Marco

More information

Diagnostic and Prognostic Value of Coronary Ca Score

Diagnostic and Prognostic Value of Coronary Ca Score Diagnostic and Prognostic Value of Coronary Ca Score Dr. Ghormallah Alzahrani Cardiac imaging division, Adult Cardiology department Prince Sultan Cardiac Center ( PSCC) Madina, June 2 Coronary Calcium

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005 Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque

More information

DESolve NX Trial Clinical and Imaging Results

DESolve NX Trial Clinical and Imaging Results DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or

More information

as a Mechanism of Stent Failure

as a Mechanism of Stent Failure In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I

More information

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial

More information

Declaration of conflict of interest. Nothing to disclose

Declaration of conflict of interest. Nothing to disclose Declaration of conflict of interest Nothing to disclose Hong-Seok Lim, Seung-Jea Tahk, Hyoung-Mo Yang, Jin-Woo Kim, Kyoung- Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Joon-Han

More information

Assessment of Vulnerable Plaques Causing Acute Coronary Syndrome Using Integrated Backscatter Intravascular Ultrasound

Assessment of Vulnerable Plaques Causing Acute Coronary Syndrome Using Integrated Backscatter Intravascular Ultrasound Journal of the American College of Cardiology Vol. 47, No. 4, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.09.061

More information

FFR and intravascular imaging, which of which?

FFR and intravascular imaging, which of which? FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment

More information

RESTENOSIS Facing up to the problem

RESTENOSIS Facing up to the problem RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis

More information

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Noninvasive Coronary Imaging: Plaque Imaging by MDCT Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation

More information

Usefulness of OCT during coronary intervention

Usefulness of OCT during coronary intervention Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization

More information

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Can We Identify Vulnerable Patients & Vulnerable Plaque? Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial

More information

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R 32 ο Πανελλήνιο Καρδιολογικό Συνζδριο, Θεσσαλονίκη 20/10/2011 Gould KL et al, JACC CARDIOVASC IMAG 2009 Gould KL et al AM J CARDIOL 1974 & JACC CARDIOVASC IMAG 2009 Under maximal hyperemia: Rs=Rn FFR=

More information

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 F Prati San Giovanni H. and CLI Foundation, Rome Euro Image Research Che cosa preoccupa il cardiologo

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information

Upgrade of Recommendation

Upgrade of Recommendation Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for

More information

대한심장학회춘계학술대회 Satellite Symposium

대한심장학회춘계학술대회 Satellite Symposium 대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

Post PCI functional testing and imaging: case based lessons from FFR React

Post PCI functional testing and imaging: case based lessons from FFR React Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest

More information

Prognostic Value of Gated Myocardial Perfusion SPECT

Prognostic Value of Gated Myocardial Perfusion SPECT Current Use of IVUS & FFR George D. Dangas, MD, PhD, FACC, FSCAI Professor of Medicine Mount Sinai School of Medicine Prognostic Value of Gated Myocardial Perfusion SPECT 0.6% / year, Cardiac Death and

More information

Anatomy is Destiny, But Physiology is Here Today

Anatomy is Destiny, But Physiology is Here Today Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue

More information

Management of Multivessel CAD: Stenting or CABG?

Management of Multivessel CAD: Stenting or CABG? Management of Multivessel CAD: Stenting or CABG? Filippos Triposkiadis, MD, FESC, FACC Department of Cardiology, University of Thessaly Long-term Outcome of Patients With 3VD Undergoing CABG A Report from

More information

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional

More information

Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction An Intravascular Ultrasound Study

Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction An Intravascular Ultrasound Study Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction An Intravascular Ultrasound Study Shoichi Ehara, MD; Yoshiki Kobayashi, MD; Minoru Yoshiyama, MD; Kenei Shimada,

More information

DES In-stent Restenosis

DES In-stent Restenosis DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Can We Safely Defer PCI. Yes, already proven

Can We Safely Defer PCI. Yes, already proven Can We Safely Defer PCI Just Based on FFR>0.80? Yes, already proven Seung-Jung Park, MD., PhD. Professor of Medicine, University of Ulsan, College of Medicine Heart Institute, Asan Medical Center, Seoul,

More information

Assessment of vulnerable plaque by OCT

Assessment of vulnerable plaque by OCT Assessment of vulnerable plaque by OCT Comparison with histology and possible clinical applications Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Identification of vulnerable

More information

Basics of Angiographic Interpretation Analysis of Angiography

Basics of Angiographic Interpretation Analysis of Angiography Basics of Angiographic Interpretation Analysis of Angiography Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Seoul, Korea What made us nervous Supervisors Stent Contrast

More information

Intravascular Ultrasound

Intravascular Ultrasound May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient

More information

Yukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3

Yukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3 Culprit Lesion Characteristics in Acute Coronary Syndrome and Stable Angina Assessed by Optical Coherence Tomography (OCT), Angioscopy, IVUS and Multidetector Computed Tomography (MDCT) Yukio Ozaki, M

More information

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Thomas M. Shimshak, MD Heart and Vascular Center Florida Hospital Heartland Medical Center

More information

Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease

Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease Editorial Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease Takashi Kubo, Hiroki Emori, Yosuke Katayama, Kosei Terada Department

More information

Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My

Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Invasive Imaging (IVUS, VH-IVUS, and OCT): How I Implement into My Practice Gary S. Mintz, MD Cardiovascular Research Foundation Modalities FFR IVUS (with or without VH, imap, or IB-IVUS) OCT NIRS (with

More information

Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study

Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study Evaluation COMBO s Healing Profile The EGO-COMBO Serial OCT Study OrbusNeich Dual Therapy COMBO Stent Symposium 25 th April 2013 Prof. Stephen WL Lee, JP 李偉聯 MD FRCP(Lon. Edin. Glas.) FHKCP FHKAM FACC

More information

PCI for Bifurcation Coronary Lesion

PCI for Bifurcation Coronary Lesion PCI for Bifurcation Coronary Lesion Bifurcation Lesions PCI is Challenging Higher acute complication Lower success rates Higher restenosis & TLR Restenosis Rate 21 ~ 57% TLR 8 ~ 43% Event Free Survival

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

CPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea

CPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea Coronary Artery Imaging The ideal coronary imaging technology would be capable of identifying not only vessel

More information

Sibin K Zacharias 1, Robert D Safian 1, Ryan D Madder 2, Ivan D Hanson 1, Mark C Pica 1, James L Smith 1, James A Goldstein 1 and Amr E Abbas 1

Sibin K Zacharias 1, Robert D Safian 1, Ryan D Madder 2, Ivan D Hanson 1, Mark C Pica 1, James L Smith 1, James A Goldstein 1 and Amr E Abbas 1 631420VMJ0010.1177/1358863X16631420Vascular MedicineZacharias et al. research-article2016 Original Article Invasive evaluation of plaque morphology of symptomatic superficial femoral artery stenoses using

More information

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift

THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift THE COMPLEX RELATION BETWEEN VULNERABILITY AND ISCHEMIA a paradigm shift Angioplasty Summit TCT ASIA Seoul, Korea, april 23rd, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands

More information

PCI for Chronic Total Occlusions

PCI for Chronic Total Occlusions PCI for Chronic Total Occlusions Chronic Total Occlusions Why not Medical Treatment? Medical Treatment CTO in 891 pts over 24 years High 10% Mortality Low 2 % 1 year 10 years Puma JA, et al. JACC 1994;23:390A

More information

Protection of side branch is essential in treating bifurcation lesions: overview

Protection of side branch is essential in treating bifurcation lesions: overview Angioplasty Summit TCT Asia Pacific Seoul, April 26-28, 2006 Protection of side branch is essential in treating bifurcation lesions: overview Alfredo R Galassi, MD, FACC, FSCAI, FESC Head of the Catetherization

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome

Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery Lesions in Acute Coronary Syndrome Med. J. Cairo Univ., Vol. 85, No. 4, June: 1335-1340, 2017 www.medicaljournalofcairouniversity.net Intravascular Ultrasound-Guided Management of Angiographically Intermediate Non-Culprit Coronary Artery

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Intravascular Ultrasound (IVUS)

Intravascular Ultrasound (IVUS) University Heart Journal Vol. 10, No. 2, July 2014 Intravascular Ultrasound (IVUS) S MOKADDAS HOSSAIN (SADI) Labaid Cardiac Hospital, Dhaka, Bangladesh Address of Correspondence: Dr. S Mokaddas Hossain

More information

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCIs on Intermediate Lesions NCDR Cath-PCI Registry Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further

More information

Que nos puede aportar el OCT intracoronario

Que nos puede aportar el OCT intracoronario XXXI Jornadas SOLACI. 10ª Región CONOSUR LIIIº Congreso Chileno de Cardiología y Cirugía Cardiovascular Hotel Patagónico. Puerto Varas. Chile (30 Nov 1 Dic 2016) Que nos puede aportar el OCT intracoronario

More information